D.-Z. Wang et al. / Polyhedron 42 (2012) 216–226
217
have been investigated [8b]. However, there are still only rare re-
benzoic acid / POCl
3
1
L
ports of ligands based on condensed heterocyclic based 1,2,4-tria-
zole as building blocks for the construction of coordination
complexes.
N
N
nicotinic acid / POCl
3
R
2
L
N
SH
In this work, four ligands of condensed heterocyclic based 1,2,4-
triazole: 4,7-diphenyl-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole (L1),
4-phenyl-7-(pyridine-3-yl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole
(L2), 4-phenyl-7-(pyridine-4-yl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadi-
azole (L3), and 4-(pyridine-3-yl)-7-(pyridine-4-yl)-1,2,4-triazol-
o[3,4-b]-1,3,4-thiadiazole (L4), (Chart 1), have been designed and
synthesized. The reactions of these ligands with the corresponding
metal salts lead to the formation of seven new metal–organic com-
plexes with 0-D, 1-D and 2-D network structures. Herein, we re-
port the syntheses, crystal structures and emission properties of
these complexes. The influences of the locality and amount of coor-
dination atoms in the same ligands’ framework and counteranions
on the resultant structures of their metal complexes are briefly
discussed. In addition, the emission properties of part of these
complexes have also been investigated in the solid state at room
temperature.
NH
(a)
isonicotinic acid / POCl
3
3
4
2
L , L
N
1
2
3
4
L ,L ,L : R=
L : R=
Chart 2.
2.2.2. 4-phenyl-7-(pyridine-3-yl)-1,2,4-triazolo[3,4-b]-1,3,4-
thiadiazole(L2)
Ligand L2 were obtained by the similar method described for L1.
Yield: ꢂ60%. m.p. 239–240 °C. 1H NMR (CDCl3): d: 9.21(d, 1H, J = 2
Hz, pyridine-2), 8.86(dd, 1H, J = 1.6, 5.2 Hz, phenyl-4), 8.39–
8.42(m, 2H, pyridine-4,6), 8.25–8.28(m, 1H, pyridine-5), 7.52–
7.605(m, 4H, phenyl-2, 3, 5, 6); Anal. Calc. for C14H9N5S: C, 60.2;
H, 3.25; N, 25.07; Found: C, 60.63; H, 3.22; N, 24.95%. IR (cmꢁ1
,
KBr pellets): 3325w, 3049w, 2998w, 1992w, 1916w, 1887w,
1809w, 1765w, 1732w, 1693w, 1651w, 1586m, 1571m, 1533w,
1514w, 1480s, 1460s, 1420s, 1380m, 1357m, 1335m, 1308w,
1290m, 1270m, 1244m, 1192m, 1172m, 1123m, 1096w, 1074w,
1049w, 1026m, 998w, 975s, 955s, 922m, 812s, 770s, 721w, 701s,
684s, 672s, 621m, 600m.
2. Experimental
2.1. Materials and general methods
All the other reagents used for the syntheses were commercially
available and employed without further purification. The interme-
diate of 3-phenyl-4-amino-5-sulfhydryl-1,2,4-triazole (a) was pre-
pared according to reported procedures [15]. IR spectra were
measured on a Brucker Equinox 55 FT-IR spectrometer with KBr
Pellets in the range of 4000–400 cmꢁ1. Elemental analyses of C, H
and N were performed on a Thermo Flash EA 1112-NCHS-O ana-
lyzer. 1H NMR data were collected using an INOVA-400 NMR
spectrometer. Chemical shifts are reported in relative to TMS.
Solid-state emission and excitation spectra of compounds were
measured using a Cary Eclips fluorescence spectrophotometer.
2.2.3. 4-phenyl-7-(pyridine-4-yl)-1,2,4-triazolo[3,4-b]-1,3,4-
thiadiazole(L3)
Ligand L3 were obtained by the similar method described for L1.
Yield: ꢂ55%. m.p. 234–236 °C. 1H NMR (CDCl3): d: 8.90(d, 2H,
J = 4.4 Hz, pyridine-2,6), 7.86(d, 2H, J = 4.4 Hz, pyridine-3,5),
8.40(dd, 2H, J = 1.6, 6.8 Hz phenyl-2, 6), 7.55–7.61(m, 3H, phenyl-
3, 4, 5); Anal. Calc. for C14H9N5S: C, 60.2; H, 3.25; N, 25.07; Found:
C, 60.63; H, 3.22; N, 24.95%. IR (cmꢁ1, KBr pellets): 3429m, 3074w,
3038w, 2897w, 2552w, 2447w, 1974w, 1944w, 1825w, 1779w,
1708w, 1677w, 1625w, 1597s, 1560w, 1513w, 1491w, 1467s,
1438s, 1415s, 1380m, 1359m, 1330m, 1311m, 1292m, 1268m,
1245m, 1217m, 1184m, 975s, 959s, 856w, 820s, 774s, 699s,
685s,651m, 610s, 597s.
2.2. Synthesis of L1–L4
2.2.1. 4,7-diphenyl-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole (L1)
The route of synthesis is shown in Chart 2, the intermediate of
3-phenyl-4-amino-5-sulfhydryl-1,2,4-triazole (a) (5 mmol) and
benzoic acid (5 mmol) was added to freshly distilled POCl3
(20 mL). After heating in an oil bath at 120° for 8 h, then removing
excess POCl3 under depress pressure. Poured reactor into cold
water, neutralized with NaOH to give ligand L1, recrystallized from
absolute ethanol to give ligand L1 as white crystals. Yield: ꢂ65%.
m.p. 209–211 °C. 1H NMR (CDCl3): d: 7.50–8.44(m, 10H, phenyl);
Anal. Calc. for C15H10N4S: C, 64.73; H, 3.62; N, 20.13; Found: C,
64.92; H, 3.54; N, 20.24%. IR (cmꢁ1, KBr pellets): 3061w, 3028w,
2895w, 1971w, 1903w, 1809w, 1774w, 1685w, 1655w, 1595w,
1578w, 1512m, 1469s, 1436m, 1380m, 1358m, 1311m, 1289m,
1268m, 1238m, 1175w, 1155w, 1108w, 1075m, 1022w, 1000m,
975s, 954m, 919m, 798w, 772s, 765s, 714w, 683s, 651m, 617m,
606m.
2.2.4. 4-(pyridine-3-yl)-7-(pyridine-4-yl)-1,2,4-triazolo[3,4-b]-1,3,4-
thiadiazole(L4)
Ligand L4 were obtained by the similar method described for L1.
Yield: ꢂ45%. m.p. 231–232 °C. 1H NMR (CDCl3): d: 7.26–9.67(m,
8H, pyridine); Anal. Calc. for C13H8N6S: C, 55.70; H, 2.88; N,
29.98; Found: C, 55.64; H, 2.93; N, 28.95%. IR (cmꢁ1, KBr pellets):
3030m, 2894w, 2433w, 1942w, 1698w, 1629w, 1595s, 1571s,
1523s, 1510s, 1486s, 1470s, 1455s, 1409s, 1379s, 1332m, 1310m,
1278s, 1248s, 1220m, 1191s, 1119m, 1095m, 1066m, 1028m,
979s, 962s, 825s, 807s, 723m, 703s, 692s, 653s, 614s, 600s, 497m,
408m.
N
N
N N
N
N
N N
N
N
S
N
S
N
N
S
S
N
N
N
N
N
N
N
L1
L2
L3
L4
Chart 1.